biote Corp.: Business Overview, Financials & Competitive Analysis
biote Corp. scores 5/10 on the AskCyborg Cyborg Score (Mixed). Specialized hormone replacement therapy platform with network effects, but execution and market adoption risks limit growth trajectory. biote Corp. operates in a growing wellness segment with a recurring revenue model and network effects through its certified practitioner platform. However, limited scale (217 employees), significant public market volatility, and reliance on.
What is biote Corp.'s industry? biote Corp. (biote.com) operates in Enodcrinology. AskCyborg classifies biote Corp. under Enodcrinology in its company registry.
biote Corp. is a Delaware incorporated company headquartered in Irving, Texas, founded in 2012 that trains physicians and nurse practitioners in therapeutic wellness and hormone optimization using bioidentical hormone...
Cyborg Score thesis
Specialized hormone replacement therapy platform with network effects, but execution and market adoption risks limit growth...
Read the full analyst-debate transcript →Get the Latest biote Corp. Report
Up-to-date AI-powered research, analyst debate audio & saved-company playlists
Get Current Report Freebiote Corp. Overview
Pro stress-test →biote Corp. is a Delaware incorporated company headquartered in Irving, Texas, founded in 2012 that trains physicians and nurse practitioners in therapeutic wellness and hormone optimization using bioidentical hormone replacement pellet therapy in men and women experiencing hormonal imbalance. The company offers the Biote Method, a comprehensive end-to-end practice building platform that provides Biote-certified practitioners with education, training, certification, practice management software, and inventory management tools.
Strategic Profile
Pro stress-test →biote Corp. operates a practice-building business within the hormone optimization space, providing the necessary components to enable Biote-certified practitioners to establish, build and implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company also sells dietary supplements under the Biote brand and sterile pellet insertion kits used with hormone optimization therapies for male and female.
Competitive Landscape
Pro stress-test →biote Corp. competes in the bioidentical hormone replacement therapy market against traditional pharmaceutical companies offering synthetic hormone therapies and alternative wellness platforms. Direct competitors include companies offering hormone optimization services and practice-building platforms to independent practitioners, though the market remains relatively fragmented. The company's competitive advantage derives from its integrated certification and software platform that locks in practitioners and creates switching costs.
Industry Context
biote Corp. operates in Enodcrinology.
Key facts
Founded: 2012 · Headquarters: Irving, Texas, US · Employees: 217 · Revenue: Estimated $100M-$150M (based on 2024 public market signals; exact revenue from SEC filings not fully extracted)